Eric Groen - 21 Mar 2024 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RANI	Stock Option (Right to Buy)	Award	$0	+323,500		$0.000000	323,500	21 Mar 2024	Class A Common Stock	323,500	$3.60	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024.